Skip to main content
OpenTrials

Clinical trial condition

Respiratory Tract Diseases

Explore clinical trials studying Respiratory Tract Diseases. Study availability and eligibility vary by location and protocol.

37,292 public trials 4,949 recruiting studies
Refine in advanced search Browse all conditions

Respiratory Tract Diseases trial results

Recruiting

A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases

NCT06806592

Conditions
Interstitial Lung Diseases, Lung Diseases, Lung Diseases, Interstitial, +2 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Mayo Clinic-Arizona Scottsdale, Arizona, United States
  • University of California Los Angeles Los Angeles, California, United States
  • Paradigm Clinical Research - San Diego San Diego, California, United States
View all 154 locations
View Trial Details
Recruiting

A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

NCT06793215

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Alaska Oncology and Hematology Anchorage, Alaska, United States
  • City of Hope - Phoenix Goodyear, Arizona, United States
  • Marin Cancer Care Inc Greenbrae, California, United States
  • Hoag Memorial Hospital Newport Beach, California, United States
View all 280 locations
View Trial Details
Recruiting

A Study Evaluating Disease Characteristics and Outcomes in Participants With Asthma in Routine Clinical Practice

NCT07556159

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • Chandler Clinical Trials - Site Number: 840106 Chandler, Arizona, United States
  • Del Sol Research Management, LLC - Mesa - Site Number: 840123 Mesa, Arizona, United States
  • Sun City Clinical Trials - Elite - Site Number: 840120 Sun City, Arizona, United States
  • FOMAT - Huntington Asthma & Allergy Center - Site Number: 840158 California City, California, United States
View all 62 locations
View Trial Details
Recruiting

A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

NCT06568939

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Ironwood Cancer and Research Center /ID# 276370 Chandler, Arizona, United States
  • University of Arkansas for Medical Sciences /ID# 272923 Little Rock, Arkansas, United States
  • Valkyrie Clinical Trials /ID# 271322 Los Angeles, California, United States
  • Yale New Haven Hospital /ID# 271584 New Haven, Connecticut, United States
View all 80 locations
View Trial Details
Recruiting

A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors

NCT06561685

Conditions
Adenocarcinoma, Advanced Solid Tumor, Bronchial Neoplasms, +21 more
Locations
  • UCLA Santa Monica, California, United States
  • University of Colorado Health Hospital Aurora, Colorado, United States
  • Sarah Cannon Research Institute at HealthOne Denver, Colorado, United States
  • Florida Cancer Specialists ORLANDO/DDU Lake Mary, Florida, United States
View all 33 locations
View Trial Details
Recruiting

inDividual, Targeted thrombosIS Prophylaxis Versus the Standard 'One Size Fits All' Approach in Patients Undergoing Total hIp or Total kNee replaCemenT

NCT06581965

Conditions
Cardiovascular Diseases, Deep Vein Thrombosis, Embolism, +10 more
Locations
  • Gelre Ziekenhuizen Apeldoorn, Gelderland, Netherlands
  • Zuyderland Geleen, Limburg, Netherlands
  • Anna Ziekenhuis Geldrop, North Brabant, Netherlands
  • Elisabeth-TweeSteden Ziekenhuis Tilburg, North Brabant, Netherlands
View all 13 locations
View Trial Details
Recruiting

A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)

NCT07361510

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Southern Cancer Center Pc Daphne, Alabama, United States
  • Mohtaseb Cancer Center & Blood Disorders Bullhead City, Arizona, United States
  • Palo Verde Hematology Oncology Glendale, Arizona, United States
  • Orange Coast Memorial Medical Center Fountain Valley, California, United States
View all 279 locations
View Trial Details

Related conditions